v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (12,284,233) $ (2,407,174)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of original issue discount 844,535 6,322
Depreciation expense 3,907
Realized loss on equity investment 41,000
Gain on extinguishment of liabilities (18,301)
Equity-based compensation 958,762 4,878
Changes in operating assets and liabilities:    
Accounts receivable (25,867) 126,821
Inventories 38,305 105,047
Prepaid expenses and other 2,822 (38,646)
Interest receivable (41,293)
Accounts payable 947,693 647,600
Accrued compensation 383,093
Settlement payable (124,559)
Accrued creator commissions 90,376
Accrued expenses (124,346) 209,085
Accrued sales tax 153,259
Deferred revenue (940,615) (722)
Net cash used in operating activities (9,776,973) (1,346,789)
Cash flows from investing activities    
Cash acquired through acquisition (Note 2) 591,686
Issuance of note receivable (900,000)
Net cash used in investing activities (308,314)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from notes payable net of issuance costs 3,466,489 42,500
Proceeds from financing arrangement net of issuance cost 225,000
Proceeds from convertible notes payable and warrants 1,719,121 300,000
Proceeds from issuance of Series B preferred stock - net of issuance costs 805,017
Proceeds from issuance of Series C preferred stock - net of issuance costs 703,047
Repayment of financing arrangement (933,228)
Warrants issued in conjunction with debt 422,961
Commencement shares issued with debt 162,245  
Payments on note payable (15,000)
Issuance of common stock from Equity Line of Credit – net of issuance costs 4,293,186  
Issuance of common stock in conjunction with securities purchase agreement 262,500
Net cash provided by financing activities 10,228,566 1,132,517
Net change in cash and restricted cash 144,291 (214,272)
Cash and restricted cash at beginning of period 155,647 336,340
Cash and restricted cash at end of period 299,938 122,068
Supplemental disclosure of cash flow information:    
Acquisition through issuance of Series D and Merger Warrants 75,000,000
Repayment of debt with investment 521,260
Forgiveness of note receivable and interest with note payable and interest from Acquisition 4,478,181
Warrants issued in conjunction with debt 422,961 131,353
Issuance cost in conjunction with name change 56,667
Accrued Series A dividends $ 140,133 $ 106,133

Source

10-Q PDF XBRL Zip